{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:49:15Z","timestamp":1790250555104,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12876-015-0308-0","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T12:14:09Z","timestamp":1436271249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["HBV genotypes and response to tenofovir disoproxil fumarate in HIV\/HBV-coinfected persons"],"prefix":"10.1186","volume":"15","author":[{"name":"Swiss HIV Cohort Study","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bihl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Martinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Wandeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ledergeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Calmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Cavassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Vernazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Paola","family":"Caminada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rickenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"issue":"19","key":"308_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMp1201796","volume":"366","author":"AP Kourtis","year":"2012","unstructured":"Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ. HIV-HBV coinfection--a global challenge. N Engl J Med. 2012;366(19):1749\u201352.","journal-title":"N Engl J Med"},{"issue":"15","key":"308_CR2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166(15):1632\u201341.","journal-title":"Arch Intern Med"},{"issue":"6","key":"308_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","volume":"42","author":"D Salmon-Ceron","year":"2005","unstructured":"Salmon-Ceron D, Lewden C, Morlat P, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42(6):799\u2013805.","journal-title":"J Hepatol"},{"issue":"1","key":"308_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ije\/dyh307","volume":"34","author":"C Lewden","year":"2005","unstructured":"Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34(1):121\u201330.","journal-title":"Int J Epidemiol"},{"issue":"9349","key":"308_CR5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky Jr R, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360(9349):1921\u20136.","journal-title":"Lancet"},{"issue":"5","key":"308_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/QAI.0b013e3180314b46","volume":"44","author":"B Ramos","year":"2007","unstructured":"Ramos B, Nunez M, Martin-Carbonero L, et al. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV\/hepatitis B virus-coinfected patients. J Acquir Immune Defic Syndr. 2007;44(5):557\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"308_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1089\/aid.2006.22.842","volume":"22","author":"M Nunez","year":"2006","unstructured":"Nunez M, Ramos B, Diaz-Pollan B, et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retroviruses. 2006;22(9):842\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"308_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/00002030-200307250-00009","volume":"17","author":"L Cooley","year":"2003","unstructured":"Cooley L, Ayres A, Bartholomeusz A, et al. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. AIDS. 2003;17(11):1649\u201357.","journal-title":"AIDS"},{"issue":"5","key":"308_CR9","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.gastro.2003.03.006","volume":"125","author":"G Zehender","year":"2003","unstructured":"Zehender G, De Maddalena C, Milazzo L, et al. Hepatitis B virus genotype distribution in HIV-1 coinfected patients. Gastroenterology. 2003;125(5):1559\u201360. author reply 660.","journal-title":"Gastroenterology"},{"issue":"3","key":"308_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.aids.0000200537.86984.0e","volume":"20","author":"K Lacombe","year":"2006","unstructured":"Lacombe K, Massari V, Girard PM, et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS. 2006;20(3):419\u201327.","journal-title":"AIDS"},{"issue":"3","key":"308_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/jac\/dkp479","volume":"65","author":"V Soriano","year":"2010","unstructured":"Soriano V, Mocroft A, Peters L, et al. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother. 2010;65(3):548\u201355.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"308_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QAD.0b013e328340fde2","volume":"25","author":"L Martin-Carbonero","year":"2011","unstructured":"Martin-Carbonero L, Teixeira T, Poveda E, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS. 2011;25(1):73\u20139.","journal-title":"AIDS"},{"issue":"13","key":"308_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/QAD.0b013e32832b43f2","volume":"23","author":"GV Matthews","year":"2009","unstructured":"Matthews GV, Seaberg E, Dore GJ, et al. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV\/HBV coinfected individuals. AIDS. 2009;23(13):1707\u201315.","journal-title":"AIDS"},{"issue":"9","key":"308_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/01.aids.0000171404.07995.5c","volume":"19","author":"K Lacombe","year":"2005","unstructured":"Lacombe K, Gozlan J, Boelle PY, et al. Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate. Aids. 2005;19(9):907\u201315.","journal-title":"Aids"},{"issue":"2","key":"308_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1468-1293.2007.00535.x","volume":"9","author":"JK Rockstroh","year":"2008","unstructured":"Rockstroh JK, Bhagani S, Benhamou Y, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med. 2008;9(2):82\u20138.","journal-title":"HIV Med"},{"issue":"2","key":"308_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep.26686","volume":"59","author":"KM Kitrinos","year":"2014","unstructured":"Kitrinos KM, Corsa A, Liu Y, et al. No detectable resistance to tenofovir disoproxil fumarate after 6\u00a0years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59(2):434\u201342.","journal-title":"Hepatology"},{"issue":"8","key":"308_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/QAD.0b013e328345ef5e","volume":"25","author":"L Ratcliffe","year":"2011","unstructured":"Ratcliffe L, Beadsworth MB, Pennell A, Phillips M, Vilar FJ. Managing hepatitis B\/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil\/emtricitabine) experienced patients. AIDS. 2011;25(8):1051\u20136.","journal-title":"AIDS"},{"issue":"6","key":"308_CR18","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1053\/j.gastro.2010.08.045","volume":"139","author":"TE Vries-Sluijs de","year":"2010","unstructured":"de Vries-Sluijs TE, Reijnders JG, Hansen BE, et al. Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology. 2010;139(6):1934\u201341.","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"308_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000150411","volume":"38","author":"LO Magnius","year":"1995","unstructured":"Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995;38(1\u20132):24\u201334.","journal-title":"Intervirology"},{"issue":"3","key":"308_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","volume":"118","author":"JH Kao","year":"2000","unstructured":"Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118(3):554\u20139.","journal-title":"Gastroenterology"},{"issue":"3","key":"308_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jhep.2007.04.011","volume":"47","author":"M Buti","year":"2007","unstructured":"Buti M, Elefsiniotis I, Jardi R, et al. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. J Hepatol. 2007;47(3):366\u201372.","journal-title":"J Hepatol"},{"issue":"16","key":"308_CR22","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/jnci\/djn243","volume":"100","author":"HI Yang","year":"2008","unstructured":"Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100(16):1134\u201343.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"308_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jmv.1069","volume":"64","author":"T Koibuchi","year":"2001","unstructured":"Koibuchi T, Hitani A, Nakamura T, et al. Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. J Med Virol. 2001;64(4):435\u201340.","journal-title":"J Med Virol"},{"issue":"5","key":"308_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/ije\/dyp321","volume":"39","author":"F Schoeni-Affolter","year":"2010","unstructured":"Schoeni-Affolter F, Ledergerber B, Rickenbach M, et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol. 2010;39(5):1179\u201389.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"308_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10096-006-0223-y","volume":"26","author":"D Olioso","year":"2007","unstructured":"Olioso D, Boaretti M, Ligozzi M, Lo Cascio G, Fontana R. Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis. 2007;26(1):43\u201350.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"308_CR26","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1128\/JCM.41.12.5473-5477.2003","volume":"41","author":"C Osiowy","year":"2003","unstructured":"Osiowy C, Giles E. Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype. J Clin Microbiol. 2003;41(12):5473\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"308_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/bib\/bbn017","volume":"9","author":"S Kumar","year":"2008","unstructured":"Kumar S, Nei M, Dudley J, Tamura K. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform. 2008;9(4):299\u2013306.","journal-title":"Brief Bioinform"},{"issue":"2","key":"308_CR28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/JCM.38.2.702-707.2000","volume":"38","author":"L Stuyver","year":"2000","unstructured":"Stuyver L, Van Geyt C, De Gendt S, et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol. 2000;38(2):702\u20137.","journal-title":"J Clin Microbiol"},{"issue":"Pt 12","key":"308_CR29","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1099\/vir.0.2008\/005124-0","volume":"89","author":"C Osiowy","year":"2008","unstructured":"Osiowy C, Gordon D, Borlang J, Giles E, Villeneuve JP. Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada. J Gen Virol. 2008;89(Pt 12):3009\u201315.","journal-title":"J Gen Virol"},{"issue":"8","key":"308_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/088922203322280874","volume":"19","author":"M Perez-Olmeda","year":"2003","unstructured":"Perez-Olmeda M, Nunez M, Garcia-Samaniego J, Rios P, Gonzalez-Lahoz J, Soriano V. Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications. AIDS Res Hum Retroviruses. 2003;19(8):657\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"41","key":"308_CR31","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.3748\/wjg.v11.i41.6525","volume":"11","author":"ZM Huang","year":"2005","unstructured":"Huang ZM, Huang QW, Qin YQ, et al. Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population. World J Gastroenterol. 2005;11(41):6525\u20139.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"308_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.hepres.2006.04.010","volume":"35","author":"P Jutavijittum","year":"2006","unstructured":"Jutavijittum P, Jiviriyawat Y, Yousukh A, Kunachiwa W, Toriyama K. Genotypes of hepatitis B virus among voluntary blood donors in northern Thailand. Hepatol Res. 2006;35(4):263\u20136.","journal-title":"Hepatol Res"},{"issue":"2","key":"308_CR33","doi-asserted-by":"publisher","first-page":"e30245","DOI":"10.1371\/journal.pone.0030245","volume":"7","author":"IE Andernach","year":"2012","unstructured":"Andernach IE, Jutavijittum P, Samountry B, et al. A high variability of mixed infections and recent recombinations of hepatitis B virus in Laos. PLoS One. 2012;7(2):e30245.","journal-title":"PLoS One"},{"issue":"Pt 9","key":"308_CR34","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1099\/vir.0.043042-0","volume":"93","author":"B Beggel","year":"2012","unstructured":"Beggel B, Neumann-Fraune M, Doring M, et al. Genotyping hepatitis B virus dual infections using population-based sequence data. J Gen Virol. 2012;93(Pt 9):1899\u2013907.","journal-title":"J Gen Virol"},{"issue":"2","key":"308_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/hep.27182","volume":"60","author":"A Boyd","year":"2014","unstructured":"Boyd A, Gozlan J, Maylin S, et al. Persistent viremia in human immunodeficiency virus\/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications. Hepatology. 2014;60(2):497\u2013507.","journal-title":"Hepatology"},{"issue":"9","key":"308_CR36","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1093\/cid\/cit002","volume":"56","author":"GV Matthews","year":"2013","unstructured":"Matthews GV, Seaberg EC, Avihingsanon A, et al. Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus. Clin Infect Dis. 2013;56(9):e87\u201394.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"308_CR37","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1128\/JVI.02124-09","volume":"84","author":"M Crane","year":"2010","unstructured":"Crane M, Sirivichayakul S, Chang JJ, et al. No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy. J Virol. 2010;84(6):2657\u201365.","journal-title":"J Virol"},{"issue":"4","key":"308_CR38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/hep.22790","volume":"49","author":"S Amini-Bavil-Olyaee","year":"2009","unstructured":"Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, Tacke F. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. Hepatology. 2009;49(4):1158\u201365.","journal-title":"Hepatology"},{"issue":"1","key":"308_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1478-3231.2011.02601.x","volume":"32","author":"O Lada","year":"2012","unstructured":"Lada O, Gervais A, Branger M, et al. Long-term outcome of primary non-responders to tenofovir therapy in HIV\/HBV-co-infected patients: impact of HBV genotype G. Liver Int. 2012;32(1):93\u2013101.","journal-title":"Liver Int"},{"key":"308_CR40","doi-asserted-by":"publisher","first-page":"405390","DOI":"10.5402\/2011\/405390","volume":"2011","author":"CA Engell","year":"2011","unstructured":"Engell CA, Pham VP, Holzman RS, Aberg JA. Virologic Outcome of Using Tenofovir\/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients. ISRN Gastroenterol. 2011;2011:405390.","journal-title":"ISRN Gastroenterol"},{"issue":"5","key":"308_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/jvh.12255","volume":"21","author":"E Loggi","year":"2014","unstructured":"Loggi E, Gamal N, Bihl F, Bernardi M, Andreone P. Adaptive response in hepatitis B virus infection. J Viral Hepat. 2014;21(5):305\u201313.","journal-title":"J Viral Hepat"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-015-0308-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-015-0308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-015-0308-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-015-0308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T15:16:24Z","timestamp":1599232584000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-015-0308-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1186\/s12876-015-0308-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,8]]},"assertion":[{"value":"23 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}